找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Epigenetics in Oncology; Jianjun Chen,G. Greg Wang,Jun Lu Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licen

[复制链接]
楼主: Destruct
发表于 2025-3-23 12:17:17 | 显示全部楼层
发表于 2025-3-23 15:02:29 | 显示全部楼层
发表于 2025-3-23 20:06:25 | 显示全部楼层
American Studies oder Amerikanistik?ngs on the engagement of epitranscriptomic pathways, especially the ones associated with .-methyladenosine (m.A), in the regulation of cancer metabolism and the surrounding microenvironment. We also discuss the promising therapeutic approaches targeting RNA modifications for anti-tumor therapy.
发表于 2025-3-23 22:25:09 | 显示全部楼层
发表于 2025-3-24 02:57:26 | 显示全部楼层
https://doi.org/10.1007/978-3-030-00575-7 RNA metabolism to drive oncogenic or tumor-suppressive cellular pathways. m.A RNA methylation also plays dynamic roles within both immune cells and tumor cells to mediate the anti-tumor immune response. Finally, an emerging area of research within epitranscriptomics studies the role of m.A RNA meth
发表于 2025-3-24 07:25:51 | 显示全部楼层
American Television on British Screensso recognized as guanosine by the splicing and translation machineries, resulting in mRNA alternative splicing and protein recoding. Therefore, A-to-I RNA editing is an important mechanism that causes and regulates “RNA mutations” in both normal physiology and diseases including cancer. In this chap
发表于 2025-3-24 11:58:54 | 显示全部楼层
发表于 2025-3-24 16:00:38 | 显示全部楼层
American Writers And Radical Politics1900-39ational modification regulates functionality of EZH2 and PRC2, and how PRC2 and other epigenetic pathways crosstalk. Lastly, we will briefly touch on advances in targeting EZH2 and PRC2 dependence as cancer therapeutics.
发表于 2025-3-24 20:53:33 | 显示全部楼层
RNA Modifications in Cancer Metabolism and Tumor Microenvironmentngs on the engagement of epitranscriptomic pathways, especially the ones associated with .-methyladenosine (m.A), in the regulation of cancer metabolism and the surrounding microenvironment. We also discuss the promising therapeutic approaches targeting RNA modifications for anti-tumor therapy.
发表于 2025-3-25 01:52:34 | 显示全部楼层
Recent Advances of RNA m6A Modifications in Cancer Immunoediting and Immunotherapypathological processes, including immune system development and cancer pathogenesis. Therefore, a deeper understanding of the mechanisms by which RNA modifications impact the cancer immunoediting process can provide insight into the mechanisms of resistance to immunotherapies and the strategies that
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-19 12:54
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表